Most Read Articles
Stephen Padilla, 2 days ago
The novel coronavirus disease (COVID-19) pandemic appears to have a significant impact on oncological care, according to a study, which stresses the need for psycho-oncological support for cancer patients.
01 Aug 2020
Supplementation with probiotics may have positive effects in patients with type 2 diabetes mellitus (T2DM), reports a recent meta-analysis.
01 Aug 2020
Ensituximab, a chimeric monoclonal antibody targeting a variant of MUC5AC, shows modest clinical activity with good safety profile in patients with refractory colorectal cancer, according to data from a phase II study.
Roshini Claire Anthony, 30 Jul 2020

Frailty may indicate an increased risk of death from COVID-19, results of the COPE* study showed.

Naloxone dispensing acceptable among pharmacists, says study

04 Jul 2020

A recent survey reports acceptable dispensing of naloxone among pharmacists that serviced San Francisco safety net clinics.

Insufficient naloxone education is the most cited problem, which may be resolved by improving instructional materials, giving incentives for patient education, or mandatory training, according to the investigators.

Of the 58 respondents, most were staff (56.9 percent) or supervising pharmacists (34.5 percent). Majority of the pharmacists (92.9 percent) were aware that their pharmacy stocked naloxone, and most of them (86.6 percent) thought that it should be prescribed to some or all patients on long-term opioids.

Of the pharmacists, 82.1 percent dispensed naloxone at least once in the past 12 months. Less than half (43.4 percent) said they would want authority to furnish without a prescription, while more than half (55.2 percent) reported no problems dispensing naloxone.

Insufficient knowledge on naloxone was the most common problem mentioned, while more than half of the respondents said they were comfortable providing naloxone education. Additionally, only 12 percent reported more than one problem in dispensing naloxone, which correlated with being uncomfortable with educating patients (p=0.03).

The investigators assessed the intervention of the San Francisco Department of Public Health, which initiated naloxone prescribing at six safety net clinics. Fifty-eight pharmacists completed the survey from November 2013 through January 2015, which contained data on demographics, experiences in dispensing naloxone, and interest in prescriptive authority. Descriptive analyses were carried out, and bivariate relationships were examined.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Stephen Padilla, 2 days ago
The novel coronavirus disease (COVID-19) pandemic appears to have a significant impact on oncological care, according to a study, which stresses the need for psycho-oncological support for cancer patients.
01 Aug 2020
Supplementation with probiotics may have positive effects in patients with type 2 diabetes mellitus (T2DM), reports a recent meta-analysis.
01 Aug 2020
Ensituximab, a chimeric monoclonal antibody targeting a variant of MUC5AC, shows modest clinical activity with good safety profile in patients with refractory colorectal cancer, according to data from a phase II study.
Roshini Claire Anthony, 30 Jul 2020

Frailty may indicate an increased risk of death from COVID-19, results of the COPE* study showed.